利血平通过抑制BDNF/AKT1诱导大鼠抑郁及神经损伤
DOI:
作者:
作者单位:

1.广西医科大学;2.广西壮族自治区中医药研究院

作者简介:

通讯作者:

中图分类号:

基金项目:

广西道地药材蛤蚧活性组分介于lncRNA/miRNA调节神经可塑性及抗抑郁作用机制的研究,国家自然科学基金项目(面上项目,重点项目,重大项目)


Reserpine-Induced Depressive Behaviors and Neural Impairment in Rats: Role of BDNF/AKT1 Signaling Suppression
Author:
Affiliation:

1.Guangxi Medical University,Guangxi Nanning;2.Guangxi Institute of Chinese Medicine and Pharmaceutical Science,Guangxi Key Laboratory of Chinese Medicine Quality Standard,Guangxi Nanning

Fund Project:

Study on the mechanism of the active components of Gekko gecko in Guangxi between lncRNA / miRNA regulating neural plasticity and antidepressant effect,China Postdoctoral Science Foundation,The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 本文旨在运用网络毒理学、分子对接、动物模型行为学评估及组织病理学分析等实验验证,系统揭示利血平致抑郁的分子机制。方法 基于多数据库网络毒理学筛选核心靶点,构建PPI网络并通过分子对接验证核心靶点。将SD大鼠随机分为对照组和利血平(0.5 mg·kg-1)给药组,给予相应剂量药物,1次/d,连续给药4 d。通过运动抑制实验、旷场实验评估行为学变化;ELISA测定血清神经递质;组织染色观察神经病理损伤;Western Blotting验证靶基因表达调控。结果 网络毒理学筛选及分子对接模拟结果表明利血平与多巴胺D2受体(DRD2)、环磷酸腺苷效应元件结合蛋白(cyclic-AMP response element binding protein, CREB)、丝氨酸/苏氨酸蛋白激酶1(serine/threonine-protein kinase 1,AKT1)结合特性显著。动物实验表明,给药组大鼠出现运动抑制等抑郁行为(P<0.05),血清中去甲肾上腺素(norepinephrine, NE)和5-羟色胺(5-hydroxytryptamine, 5-HT)水平下降(P<0.05,P<0.05),大脑皮层小胶质细胞增殖、细胞凋亡增加及海马CA1区尼氏体减少,脑组织脑源性神经生长因子(brain-derived nerve growth factor,BDNF)和海马AKT1和p-AKT1的表达下调。结论 利血平可能通过抑制BDNF、AKT1蛋白表达,影响单胺递质代谢及神经元结构完整性,导致大鼠抑郁样行为及神经损伤。

    Abstract:

    Objective This study aims to systematically elucidate the molecular mechanism of reserpine-induced depression through network toxicology, molecular docking techniques, behavioral assessments of animal models, and histopathological analyses. Methods Core targets were screened using multi-database network toxicology, followed by constructing a protein-protein interaction (PPI) network and validating core targets through molecular docking. Sprague-Dawley (SD) rats were randomly divided into a control group and a reserpine-treated group (0.5 mg·kg?1), receiving corresponding treatments once daily for 4 consecutive days. Behavioral changes were assessed using the forced swim test and open field test. Serum neurotransmitters were quantified by enzyme-linked immunosorbent assay (ELISA). Neuropathological damage was observed via tissue staining. Target gene expression regulation was verified through Western blotting. Results Network toxicology screening and molecular docking simulation results demonstrated that reserpine exhibited significant binding affinity with dopamine D2 receptor (DRD2), cyclic-AMP response element binding protein (CREB), and serine/threonine-protein kinase 1 (AKT1). Animal experiments demonstrated that the treated group displayed depression-like behaviors including motor inhibition (P<0.05), with decreased serum levels of norepinephrine (NE) and 5-hydroxytryptamine (5-HT) (P<0.05,P<0.05). Pathological observations revealed microglial proliferation in the cerebral cortex, increased apoptosis, and reduced Nissl bodies in the hippocampal CA1 region. Downregulation of brain-derived neurotrophic factor (BDNF) in brain tissue, along with decreased expression of hippocampal AKT1 and phosphorylated AKT1 (p-AKT1), was also observed. Conclusion Reserpine has been demonstrated to exert an influence on monoamine transmitter metabolism and neuronal structural integrity through the inhibition of BDNF and AKT1 protein expression, which can result in the manifestation of depressive-like behavior and cerebral nerve damage in rats.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-04-16
  • 最后修改日期:2025-05-22
  • 录用日期:2025-09-26
  • 在线发布日期:
  • 出版日期: